A Comprehensive Review of Etiology, Pathophysiology, Epidemiology, and Management of Hair Loss and Its Correlation with COVID-19

    August 2024 in “ International Journal of Medicine ”
    Faraz Changizi, Maryam Abdolmaleki, Mina Farjam, Laya Ohadi
    Studysummary In this study, researchers explored the link between COVID-19 and hair loss, finding that the virus can cause hair shedding in up to 20% of patients, potentially due to multiple factors including inflammation and psychological stress.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on sciencepubco.com →
    Discuss this study in the Community →

    Research cited in this study 52

    1. Impact of Stem Cell-Based Therapy and Platelet-Rich Plasma in Hair Loss and Telogen Effluvium Related to COVID-19 Regenerative Therapy · 2023
    2. A Case Series and Literature Review of Telogen Effluvium and Alopecia Universalis After the Administration of a Heterologous COVID-19 Vaccine Scheme Vaccines · 2023
    3. Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies International Journal of Molecular Sciences · 2022
    4. Recent Modalities in Treatment of Telogen Effluvium: Comparative Study Dermatologic Therapy · 2022
    5. Characteristics of Hair Loss After COVID-19: A Systematic Scoping Review Journal of Cosmetic Dermatology · 2022
    6. Covid Induced Telogen Effluvium: An Insight Indian Dermatology Online Journal · 2022
    7. COVID-19-Induced Scalp Alopecia Treated Effectively with Stem Cell Serum Plastic and Reconstructive Surgery – Global Open · 2022
    8. Management of Hair Loss After Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Insight Into the Pathophysiology With Implication for Better Management The Journal of Dermatology · 2022
    9. Prevalence of Telogen Effluvium Hair Loss in COVID-19 Patients and Its Relationship with Disease Severity Journal of medicine and life · 2022
    10. Evaluation of the Safety and Efficacy of Platelet-Rich Plasma in the Treatment of Female Patients with Chronic Telogen Effluvium: A Randomized, Controlled, Double-Blind, Pilot Clinical Trial Indian Journal of Dermatology, Venereology and Leprology · 2022
    11. Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium Clinical, Cosmetic and Investigational Dermatology · 2022
    12. Evaluation of Patients with Telogen Effluvium During the Pandemic: Are Monocytes Responsible for Post COVID-19 Telogen Effluvium? Journal of Cosmetic Dermatology · 2022
    13. Alopecia in Patients with COVID-19: A Systematic Review and Meta-Analysis JAAD International · 2022
    14. Association Between Alopecia Areata and COVID-19: A Systematic Review JAAD International · 2022
    15. Alopecia Areata: Current Understanding and Management Journal der Deutschen Dermatologischen Gesellschaft · 2022
    16. A Systematic Review of Acute Telogen Effluvium, a Harrowing Post-COVID-19 Manifestation Journal of Medical Virology · 2021
    17. COVID-19 Infection Is a Major Cause of Acute Telogen Effluvium Irish Journal of Medical Science (1971 -) · 2021
    18. Time of Onset and Duration of Post-COVID-19 Acute Telogen Effluvium Journal of The American Academy of Dermatology · 2021
    19. Mild-To-Moderate COVID-19 Is Not Associated With Worsening Of Alopecia Areata: A Retrospective Analysis Of 32 Patients Journal of The American Academy of Dermatology · 2021
    20. Male and Female Pattern Hair Loss: Treatable and Worth Treating Cleveland Clinic Journal of Medicine · 2021
    21. Rapidly Progressive Alopecia Areata Totalis in a COVID-19 Patient, Unresponsive to Tofacitinib Journal of the European Academy of Dermatology and Venereology · 2021
    22. Italian Survey for the Evaluation of the Effects of Coronavirus Disease 2019 Pandemic on Alopecia Areata Recurrence Dermatology and Therapy · 2021
    23. Telogen Effluvium Associated with COVID-19 Infection Dermatologic Therapy · 2021
    24. Efficacy of Oral Vitamin D3 Therapy in Patients Suffering from Diffuse Hair Loss (Telogen Effluvium) Journal of Nutritional Science and Vitaminology · 2021
    25. Telogen Effluvium After SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms Skin appendage disorders · 2021
    26. Shedding Light on Therapeutics in Alopecia and Their Relevance to COVID-19 Clinics in Dermatology · 2020
    27. A Surge in the Incidence of Telogen Effluvium in Minority Predominant Communities Heavily Impacted by COVID-19 Journal of The American Academy of Dermatology · 2020
    28. Common Causes of Hair Loss: Clinical Manifestations, Trichoscopy, and Therapy Journal of the European Academy of Dermatology and Venereology · 2020
    29. Telogen Effluvium Related to Post Severe SARS-CoV-2 Infection: Clinical Aspects and Our Management Experience Dermatologic Therapy · 2020
    30. Alopecia and Grey Hair Are Associated with COVID-19 Severity Experimental Dermatology · 2020
    31. Female Pattern Hair Loss: A Comprehensive Review Dermatologic Therapy · 2020
    32. Telogen Effluvium: A Review of the Literature Cureus · 2020
    33. Italian Guidelines in Diagnosis and Treatment of Alopecia Areata Giornale italiano di dermatologia e venereologia · 2019
    34. Frequency of the Types of Alopecia at Twenty-Two Specialist Hair Clinics: A Multicenter Study Skin appendage disorders · 2019
    35. Expert Consensus on the Management of Telogen Effluvium in India International Journal of Trichology · 2019
    36. Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata JAMA Dermatology · 2018
    37. Reply to: Updated Diagnostic Criteria for Frontal Fibrosing Alopecia Journal of The American Academy of Dermatology · 2017
    38. Alopecia Areata: Overview and Insights from January 2018 Journal of The American Academy of Dermatology · 2017
    39. Updated Diagnostic Criteria for Frontal Fibrosing Alopecia Journal of The American Academy of Dermatology · 2017
    40. The Role of Vitamin D in Non-Scarring Alopecia International Journal of Molecular Sciences · 2017
    41. Hair Loss: Common Causes and Treatment PubMed · 2017
    42. Treatment of Chronic Telogen Effluvium with Oral Minoxidil: A Retrospective Study F1000Research · 2017
    43. A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents Frontiers in Medicine · 2017
    44. The Diagnosis and Treatment of Hair and Scalp Diseases Deutsches Arzteblatt International · 2016
    45. Female Pattern Alopecia and Telogen Effluvium: Figuring Out Diffuse Alopecia Seminars in Cutaneous Medicine and Surgery · 2015
    46. Possible Relationship Between Chronic Telogen Effluvium and Changes in Lead, Cadmium, Zinc, and Iron Total Blood Levels in Females: A Case-Control Study International Journal of Trichology · 2015
    47. Telogen Effluvium: A Review Journal of Clinical and Diagnostic Research · 2015
    48. Telogen Effluvium: A Review of Acute and Chronic Forms Indian Journal of Dermatology, Venereology and Leprology · 2013
    49. Hair and Scalp Dermatoscopy Journal of The American Academy of Dermatology · 2012
    50. Dihydrotestosterone-Inducible IL-6 Inhibits Elongation of Human Hair Shafts by Suppressing Matrix Cell Proliferation and Promotes Regression of Hair Follicles in Mice Journal of Investigative Dermatology · 2011
    51. Diffuse Hair Loss in an Adult Female: Approach to Diagnosis and Management Indian Journal of Dermatology, Venereology and Leprology · 2009
    52. Androgenetic Alopecia and Microinflammation International Journal of Dermatology · 2000